Literature DB >> 15081560

Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.

Ivan Bank1, Michael P R B Scavenius, Harry R Büller, Saskia Middeldorp.   

Abstract

To explore social aspects of asymptomatic carriership of factor V Leiden mutation (FVL) and how carriers have experienced procedure of screening for FVL, we have performed a qualitative study using semi-structured interviews. Seventeen carriers of FVL without history of venous thromboembolism (VTE) were interviewed. Carriership of FVL has the potential to influence daily life by inducing concerns, stigmatisation and problems with insurances. Furthermore, proper procedure of screening is important because carriers have many questions concerning progeny, risk factors for VTE and preventive measures. Both health worker and the individual to be screened for FVL need to be fully aware of the possible consequences of screening and the fact that proper screening comprises more than only the collection of a blood sample or explaining the amount of risk for VTE induced by a genetic defect. Any guideline to be developed for the screening for FVL should take this into account too.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081560     DOI: 10.1016/j.thromres.2004.02.002

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

Review 1.  Role of thrombophilia testing: con.

Authors:  Scott M Stevens
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

Review 2.  Inherited thrombophilia: a double-edged sword.

Authors:  Saskia Middeldorp
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Cognitive and behavioural effects of genetic testing for thrombophilia.

Authors:  J Heshka; C Palleschi; B Wilson; J Brehaut; J Rutberg; H Etchegary; N Langlois; M Rodger; P S Wells
Journal:  J Genet Couns       Date:  2008-02-21       Impact factor: 2.537

Review 4.  Genetic counseling for inherited thrombophilias.

Authors:  Elizabeth A Varga
Journal:  J Thromb Thrombolysis       Date:  2007-10-19       Impact factor: 2.300

Review 5.  Evidence-based approach to thrombophilia testing.

Authors:  Saskia Middeldorp
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

6.  "Am I carrier?" The patient's lived experience of thrombophilia genetic screening and its outcome.

Authors:  Guendalina Graffigna; Daniela Leone; Elena Vegni
Journal:  Health Psychol Behav Med       Date:  2014-06-04

Review 7.  Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

Authors:  Scott M Stevens; Scott C Woller; Kenneth A Bauer; Raj Kasthuri; Mary Cushman; Michael Streiff; Wendy Lim; James D Douketis
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

Review 8.  Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test.

Authors:  C Heleen van Ommen; Ulrike Nowak-Göttl
Journal:  Front Pediatr       Date:  2017-03-14       Impact factor: 3.418

Review 9.  Inherited thrombophilia: key points for genetic counseling.

Authors:  Elizabeth Varga
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.717

10.  The influence of medical testing on patients' health: an overview from the gynecologists' perspective.

Authors:  Jolande Y Vis; Myra C B van Zwieten; Patrick M M Bossuyt; Karel G M Moons; Marcel G W Dijkgraaf; Kirsten J McCaffery; Ben Willem J Mol; Brent C Opmeer
Journal:  BMC Med Inform Decis Mak       Date:  2013-10-10       Impact factor: 2.796

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.